Predisposition Biomarkers: Technologies and Global Markets

Report Includes:

- An overview of technologies and global markets for the predisposition biomarkers
- Analyses of the global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Information on recent key technical advances in different predisposition biomarkers, as well as the extent of adoption by commercial customers and regulatory authorities
- Identification of key areas of growth and the key strategies of major players in the market
- A look at recent diagnostic test developments and revelations as well as knowledge of how they will influence selected clinical markets

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Market Definition
Key Takeaways
Key Recommendations
Chapter 4 Market Breakdown by End User
Hospitals
Research Institutes
Chapter 5 Market Breakdown by Application
Cancer
Neurological Diseases
Cardiovascular Diseases
Diabetes
Other Diseases
Chapter 6 Market Breakdown by Region
North America
United States
Canada
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of World
Chapter 7 Patent Review and New Developments
Recent Developments
Chapter 8 Competitive Landscape
BioMerieux Inc.
Recent Developments
F. Hoffmann-La Roche Ltd.
Recent Developments
Merck KGaA
Recent Developments
QIAGEN N.V.
Recent Developments
Thermo Fisher Scientific Inc.
Recent Developments
Myriad Genetics Inc.
Recent Developments
Chapter 9 Company Profiles
ABCODIA LTD.
ADMERA HEALTH
ADX NEUROSCIENCES NV
AMPRION INC.
BIO-RAD LABORATORIES INC.
COMPUGEN LTD.
EPIGENOMICS AG
MIRNAXBIOSENS, S.L
ONCIMMUNE LTD.
OPTOS PLC

List Of Tables


Summary Table : Global Market for Predisposition Biomarkers, by Application, Through 2024
Table 1 : Global Market for Predisposition Biomarkers, by End User, Through 2024
Table 2 : Global Market for the Application of Predisposition Biomarkers in Hospitals, by Region, Through 2024
Table 3 : Global Market for the Application of Predisposition Biomarkers in Research Institutes by Region, Through 2024
Table 4 : Research Institutes Working on Cancer Studies Across the Globe
Table 5 : Global Market for Predisposition Biomarkers, by Application, Through 2024
Table 6 : Clinically Relevant Biomarkers for Lung Cancer
Table 7 : Global Market for Cancer Predisposition Biomarkers, by Region, Through 2024
Table 8 : Global Incidence and Prevalence of Common Neurological Diseases, 2017
Table 9 : Global Market for Neurological Predisposition Biomarkers, by Region, Through 2024
Table 10 : List of Biomarkers Associated with CVDs
Table 11 : Global Market for Predisposition Biomarkers for CVDs, by Region, Through 2024
Table 12 : Global Market for Diabetes Predisposition Biomarkers, by Region, Through 2024
Table 13 : Characteristics of Biomarkers for Prediabetes, Diabetes and Associated Complications
Table 14 : Global Market for Other Applications of Predisposition Biomarkers, by Region, Through 2024
Table 15 : Global Market for Predisposition Biomarkers, by Region, Through 2024
Table 16 : North American Market for Predisposition Biomarkers, by Country, Through 2024
Table 17 : North American Market for Predisposition Biomarkers, by End User, Through 2024
Table 18 : North American Market for Predisposition Biomarkers, by Application, Through 2024
Table 19 : Active Early Detection Research Network Grants in the U.S., 2019
Table 20 : Funding for Research on Biomarkers for Alzheimers in Canada
Table 21 : European Market for Predisposition Biomarkers, by Country, Through 2024
Table 22 : European Market for Predisposition Biomarkers, by End User, Through 2024
Table 23 : European Market for Predisposition Biomarkers, by Application, Through 2024
Table 24 : Cancer Incidences and Mortalities in Europe, 2018
Table 25 : Major Neurological Incidences in Europe in 2017
Table 26 : Asia-Pacific Market for Predisposition Biomarkers, by Country, Through 2024
Table 27 : Asia-Pacific Market for Predisposition Biomarkers, by Application, Through 2024
Table 28 : Asia-Pacific Market for Predisposition Biomarkers, by End User, Through 2024
Table 29 : Cancer Incidence and Mortalities in Asia-Pacific, 2018
Table 30 : Active Dementia Research Grants in Australia
Table 31 : Rest of the World Market for Predisposition Biomarkers, by Application, Through 2024
Table 32 : Rest of the World Market for Predisposition Biomarkers, by End User, Through 2024
Table 33 : Number of Patents, by Country, January 2015-May 2019
Table 34 : Number of Patents, by Company/Organization
Table 35 : Number of Patents Registered, by Year
Table 36 : BioMerieux Inc.: Financial Analysis, 2017 and 2018
Table 37 : F. Hoffmann-La Roche Ltd.: Financial Analysis, 2017 and 2018
Table 38 : Merck KGaA: Financial Analysis, 2017 and 2018
Table 39 : QIAGEN N.V.: Financial Analysis, 2017 and 2018
Table 40 : Thermo Fisher Scientific Inc.: Financial Analysis, 2017 and 2018
Table 41 : Myriad Genetics Inc.: Financial Analysis, 2017 and 2018

List Of Figures


Summary Figure : Global Market for Predisposition Biomarkers, by Application, 2018-2024
Figure 1 : Global New Cancer Cases, by Type, 2018
Figure 2 : Prevalence of Cancer, by Type, 2018
Figure 3 : BioMerieux Inc.: Revenue, by Region, 2018
Figure 4 : F. Hoffmann-La Roche Ltd.: Revenue, by Operating Segment, 2018
Figure 5 : Merck KGaA: Revenue, by Region, 2018
Figure 6 : QIAGEN N.V.: Revenue, by Region, 2018
Figure 7 : Thermo Fisher Scientific Inc.: Revenue, by Region, 2018
Figure 8 : Myriad Genetics Inc.: Revenue, by Operating Segment, 2018

Predisposition Biomarkers: Technologies and Global Markets

Report Includes:- An overview of technologies and global markets for the predisposition biomarkers- Analyses of the global market trends with data from 2018, estimates for 2019, and projections of compound

USD 3950 View Report

Biomarkers: Technologies and Global Markets

Report ScopeCurrent and projected biomarker market forecasts for the forecast period 2018 to 2023 are discussed. Products approved in the last three years by the U.S. Food and Drug Administration

USD 5500 View Report

Cardiac Biomarkers: Technologies and Global Markets

Report ScopeThe principal objectives of this report are to: - Identify viable technology drivers through a comprehensive look at various platform technologies for cardiac marker segments of the diagnostic testing

USD 2750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available